Find uplifting stories about heroes, innovations, and solutions
5023 results for "alzheimer's disease"
Health Canada has authorized Kisunla, a breakthrough treatment that slows early Alzheimer's progression by 22% and can be stopped once brain plaques clear. Over 770,000 Canadians living with Alzheimer's now have access to the first disease-modifying therapy that targets the root cause of memory loss.
For the first time in history, new medications can actually slow the progression of Alzheimer's disease, not just mask symptoms. The breakthrough has sparked a wave of clinical trials and renewed hope among researchers who now believe they can change the course of this devastating condition.
After decades of studying how the brain works, scientists at Seattle's Allen Institute are launching a major effort to develop genetic therapies for previously untreatable brain diseases. The breakthrough comes from mapping millions of brain cells and understanding exactly which neurons fail in conditions like Alzheimer's, Parkinson's, and Huntington's.
Patients with early Alzheimer's now have access to Kisunla, an FDA-approved therapy that slows disease progression and helps people maintain independence longer. UToledo Health is offering the treatment, marking a major shift from managing symptoms to actually slowing the disease itself.
After two decades of setbacks, scientists have achieved a major breakthrough with Lecanemab, the first fully approved treatment that actually slows Alzheimer's progression. Over 200 more potential treatments are now racing through clinical trials, bringing real hope to millions of families.
Banner Health is testing whether combination medications can stop Alzheimer's before it starts in people with high genetic risk. The Arizona research hub is giving local families access to breakthrough treatments years before they reach the rest of the country.
A finger-prick blood test is being trialed across 1,000 people to detect Alzheimer's disease before symptoms appear, potentially replacing invasive brain scans and spinal taps. The international study could transform how millions get diagnosed with this devastating disease.
Boston scientists discovered a simple blood test can detect Alzheimer's disease years before brain scans show changes or symptoms appear. The breakthrough could help millions get earlier treatment and push back the clock on this devastating disease.
Scientists discovered specialized brain cells that sweep away toxic proteins linked to Alzheimer's disease. In people with the disease, these cells stop working properly, offering a new target for future treatments.
A newly approved Alzheimer's treatment in Malaysia can slow disease progression by more than eight years, giving patients precious extra time with their independence and loved ones. Unlike previous treatments that only managed symptoms, lecanemab actually changes how the disease progresses.
Scientists have identified three medicines already on pharmacy shelves that could help fight Alzheimer's, with a shingles vaccine leading the pack. The discovery could fast-track new treatments by years and save billions in development costs.
The FDA just approved LEQEMBI IQLIK, the first Alzheimer's treatment patients can give themselves at home from day one. The weekly autoinjector takes just 15 seconds per dose and could transform how millions manage early Alzheimer's disease. #
For the first time in history, new drugs can slow Alzheimer's progression by years, not months. Scientists say better diagnosis and funding could turn these promising treatments into a genuine cure.
A groundbreaking treatment that actually delays Alzheimer's progression just got approved in Canada, offering real hope to families facing dementia. The challenge now is making sure patients can access it.
Scientists discovered they can target multiple Alzheimer's causes simultaneously just by rearranging how molecules connect, without changing their chemical makeup. In mice, one compound reduced brain plaques, lowered oxidative stress, and improved memory.
Four leading European research institutes have joined forces to speed up treatments for Alzheimer's, Parkinson's, and other brain diseases affecting millions. The CURE-ND Alliance brings together over 2,500 scientists working to transform how we understand and treat neurodegenerative diseases.
Scientists discovered a new blood test that spots Alzheimer's by analyzing protein shapes, not amounts, potentially catching the disease years before symptoms appear. The breakthrough could transform how we diagnose and treat this devastating condition.
Doctors once thought blood tests for Alzheimer's were impossible, but breakthrough technology is now making diagnosis as simple as a routine blood draw. The tests could transform how millions get diagnosed and treated for the disease.
Massachusetts researchers are using artificial intelligence to catch Alzheimer's disease years earlier than traditional methods, when new treatments work best. The breakthrough could help millions get diagnosed before symptoms become severe.
Scientists are discovering unexpected connections between autism and Alzheimer's disease that could revolutionize how we understand and treat both conditions. What started as implausible hints in medical literature has become a promising new avenue of research.
Showing 20 of 5023